Citations should be made in the following way: Authors. Title. Eur Respir J 2017; 50: Suppl. 61, abstract number.
Citations should be made in the following way: Authors. Title. Eur Respir J 2017; 50: Suppl. 61, abstract number.
The Lancet commission on asthma
SessionChairs: S. Kleinert (London, United Kingdom), I. Pavord (Oxford, United Kingdom)
Aims: It is over 25 years since the first British asthma guidelines were published, and that asthma was identified as a disease of airway inflammation. However, progress has stalled in the past 10 years, despite increasing investment in treatment. New thinking is needed and the Lancet Commission on the asthmas aims to address three questions. First, where is this disease called “asthma” and why is it such a bad place? Second, where shall we aim to go? And finally, how will we get there, learning from our mistakes. This Commission attempts to liberate this mix of airway diseases from the protective but intellectually destitute umbrella term “asthma” with the aim to progress management to the level that is commonplace in rheumatology.